Zinc homeostasis and neurodegenerative disorders

Frontiers in Aging Neuroscience

Volumn 5, Issue JUL, 2013, Pages

  Szewczyk, Bernadeta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Aging; Alzheimer's disease; Depression; Metallothioneins; Neurodegeneration; Zinc; Zinc transporters

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ALPHA SECRETASE; ANTIDEPRESSANT AGENT; BETA SECRETASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; IMIPRAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOTHIONEIN; MULTIVITAMIN; NEURONAL NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ZINC;

AGING; AMNESIA; ANTIDEPRESSANT ACTIVITY; APOPTOSIS; BRAIN FUNCTION; BRAIN LEVEL; CEREBROSPINAL FLUID LEVEL; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; EPILEPSY; HEMODIALYSIS; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; LEARNING DISORDER; MAJOR DEPRESSION; MOLECULAR MECHANICS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYNAPSE VESICLE; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

EID: 84897366805     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00033     Document Type: Review

References (147)

1. Adlard, P. A., West, A. K., and Vickers, J. C. (1998). Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease. Neurobiol. Dis. 5, 349-356. doi: 10.1006/nbdi.1998.0203
2. Aimo, L., Cherr, G. N., and Oteiza, P. I. (2010). Low extracellular zinc increases neuronal oxidant production through nadph oxidase and nitric oxide synthase activation. Free Radic. Biol. Med. 48, 1577-1587. doi: 10.1016/j.freeradbiomed.2010.02.040
3. Aizenman, E., Stout, A. K., Hartnett, K. A., Dineley, K. E., McLaughlin, B., and Reynolds, I. J. (2000). Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J. Neurochem. 75, 1878-1888. doi: 10.1046/j.1471-4159.2000.0751878.x
4. Amani, R., Saeidi, S., Nazari, Z., and Nematpour, S. (2010). Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol. Trace Elem. Res. 137, 150-158. doi: 10.1007/s12011-009-8572-x
5. Amoureux, M. C., Van, G. D., Herrero, M. T., Dom, R., Colpaert, F. C., and Pauwels, P. J. (1997). Regulation of metallothionein-III (GIF) mRNA in the brain of patients with Alzheimer disease is not impaired. Mol. Chem. Neuropathol. 32, 101-121. doi: 10.1007/BF02815170
6. Andriollo-Sanchez, M., Hininger-Favier, I., Meunier, N., Venneria, E., O'Connor, J. M., Maiani, G., et al. (2005). Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur. J. Clin. Nutr. 59(Suppl. 2), S58-S62.
7. Baum, L., Chan, I. H., Cheung, S. K., Goggins, W. B., Mok, V., Lam, L., et al. (2010). Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals 23, 173-179. doi: 10.1007/s10534-009-9277-5
8. Besser, L., Chorin, E., Sekler, I., Silverman, W. F., Atkin, S., Russell, J. T., et al. (2009). Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J. Neurosci. 29, 2890-2901. doi: 10.1523/JNEUROSCI.5093-08.2009
9. Beyer, N., Coulson, D. T., Heggarty, S., Ravid, R., Hellemans, J., Irvine, G. B., et al. (2012). Zinc transporter mRNA levels in Alzheimer's disease postmortem brain. J. Alzheimers Dis. 29, 863-873. doi: 10.3233/JAD-2012-112105
10. Beyer, N., Coulson, D. T., Heggarty, S., Ravid, R., Irvine, G. B., Hellemans, J., et al. (2009). ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain. Mol. Neurodegener. 4:53. doi: 10.1186/1750-1326-4-53
11. Bossy-Wetzel, E., Talantova, M. V., Lee, W. D., Scholzke, M. N., Harrop, A., Mathews, E., et al. (2004). Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 41, 351-365. doi: 10.1016/S0896-6273(04)00015-7
12. Brewer, G. J., Kanzer, S. H., Zimmerman, E. A., Molho, E. S., Celmins, D. F., Heckman, S. M., et al. (2010). Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease. Am. J. Alzheimers. Dis. Other Demen. 25, 572-575. doi: 10.1177/1533317510382283
13. Burnet, F. M. (1981). A possible role of zinc in the pathology of dementia. Lancet 1, 186-188. doi: 10.1016/S0140-6736(81)90062-3
14. Bush, A. I., Pettingell, W. H., Multhaup, G., Paradis, M., Vonsattel, J. P., Gusella, J. F., et al. (1994a). Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265, 1464-1467. doi: 10.1126/science.8073293
15. Bush, A. I., Pettingell, W. H. Jr., Paradis, M. D., and Tanzi, R. E. (1994b). Modulation of A beta adhesiveness and secretase site cleavage by zinc. J. Biol. Chem. 269, 12152-12158.
16. Butterfield, D. A., Drake, J., Pocernich, C., and Castegna, A. (2001). Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol. Med. 7, 548-554. doi: 10.1016/S1471-4914(01)02173-6
17. Choi, D. W., Yokoyama, M., and Koh, J. (1988). Zinc neurotoxicity in cortical cell culture. Neuroscience 24, 67-79. doi: 10.1016/0306-4522(88)90312-0
18. Cichy, A., Sowa-Kucma, M., Legutko, B., Pomierny-Chamiolo, L., Siwek, A., Piotrowska, A., et al. (2009). Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacol. Rep. 61, 1184-1191.
19. Cieslik, K., Klenk-Majewska, B., Danilczuk, Z., Wrobel, A., Lupina, T., and Ossowska, G. (2007). Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol. Rep. 59, 46-52.
20. Corona, C., Frazzini, V., Silvestri, E., Lattanzio, R., La, S. R., Piantelli, M., et al. (2011). Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice. PLoS ONE 6:e17971. doi: 10.1371/journal.pone.0017971
21. Corona, C., Masciopinto, F., Silvestri, E., Viscovo, A. D., Lattanzio, R., Sorda, R. L., et al. (2010). Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis. 1, e91. doi: 10.1038/cddis.2010.73
22. Corrigan, F. M., Reynolds, G. P., and Ward, N. I. (1993). Hippocampal tin, aluminum and zinc in Alzheimer's disease. Biometals 6, 149-154. doi: 10.1007/BF00205853
23. Cote, A., Chiasson, M., Peralta, M. R. III., Lafortune, K., Pellegrini, L., and Toth, K. (2005). Cell type-specific action of seizure-induced intracellular zinc accumulation in the rat hippocampus. J. Physiol. 566, 821-837. doi: 10.1113/jphysiol.2005.089458
24. Cousins, R. J., Liuzzi, J. P., and Lichten, L. A. (2006). Mammalian zinc transport, trafficking, and signals. J. Biol. Chem. 281, 24085-24089. doi: 10.1074/jbc.R600011200
25. Cuajungco, M. P., and Lees, G. J. (1997). Zinc and Alzheimer's disease: is there a direct link? Brain Res. Brain Res. Rev. 23, 219-236. doi: 10.1016/S0165-0173(97)00002-7
26. Cunha, M. P., Machado, D. G., Bettio, L. E., Capra, J. C., and Rodrigues, A. L. (2008). Interaction of zinc with antidepressants in the tail suspension test. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1913-1920. doi: 10.1016/j.pnpbp.2008.09.006
27. Danscher, G., Jensen, K. B., Frederickson, C. J., Kemp, K., Andreasen, A., Juhl, S., et al. (1997). Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J. Neurosci. Methods 76, 53-59. doi: 10.1016/S0165-0270(97)00079-4
28. Daviglus, M. L., Bell, C. C., Berrettini, W., Bowen, P. E., Connolly, E. S. Jr., Cox, N. J., et al. (2010). National institutes of health state-of-the-science conference statement: preventing alzheimer disease and cognitive decline. Ann. Intern. Med. 153, 176-181. doi: 10.7326/0003-4819-153-3-201008030-00260
29. DiGirolamo, A. M., Ramirez-Zea, M., Wang, M., Flores-Ayala, R., Martorell, R., Neufeld, L. M., et al. (2010). Randomized trial of the effect of zinc supplementation on the mental health of school-age children in Guatemala. Am. J. Clin. Nutr. 92, 1241-1250. doi: 10.3945/ajcn.2010.29686
30. Dong, J., Atwood, C. S., Anderson, V. E., Siedlak, S. L., Smith, M. A., Perry, G., et al. (2003). Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42, 2768-2773. doi: 10.1021/bi0272151
31. Donnelly, P. S., Caragounis, A., Du, T., Laughton, K. M., Volitakis, I., Cherny, R. A., et al. (2008). Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide. J. Biol. Chem. 283, 4568-4577. doi: 10.1074/jbc.M705957200
32. Erickson, J. C., Sewell, A. K., Jensen, L. T., Winge, D. R., and Palmiter, R. D. (1994). Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res. 649, 297-304. doi: 10.1016/0006-8993(94)91076-6
33. Faux, N. G., Ritchie, C. W., Gunn, A., Rembach, A., Tsatsanis, A., Bedo, J., et al. (2010). PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J. Alzheimers Dis. 20, 509-516.
34. Flinn, J. M., Hunter, D., Linkous, D. H., Lanzirotti, A., Smith, L. N., Brightwell, J., et al. (2005). Enhanced zinc consumption causes memory deficits and increased brain levels of zinc. Physiol. Behav. 83, 793-803. doi: 10.1016/j.physbeh.2004.10.009
35. Franco, J. L., Posser, T., Brocardo, P. S., Trevisan, R., Uliano-Silva, M., Gabilan, N. H., et al. (2008). Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats. Behav. Brain Res. 188, 316-323. doi: 10.1016/j.bbr.2007.11.012
36. Frederickson, C. J., Suh, S. W., Silva, D., Frederickson, C. J., and Thompson, R. B. (2000). Importance of zinc in the central nervous system: the zinc-containing neuron. J. Nutr. 130, 1471S-1483S.
37. Gao, H. L., Xu, H., Xin, N., Zheng, W., Chi, Z. H., and Wang, Z. Y. (2011). Disruption of the CaMKII/CREB signaling is associated with zinc deficiency-induced learning and memory impairments. Neurotox. Res. 19, 584-591. doi: 10.1007/s12640-010-9206-y
38. Gao, H. L., Zheng, W., Xin, N., Chi, Z. H., Wang, Z. Y., Chen, J., et al. (2009). Zinc deficiency reduces neurogenesis accompanied by neuronal apoptosis through caspase-dependent and -independent signaling pathways. Neurotox. Res. 16, 416-425. doi: 10.1007/s12640-009-9072-7
39. Gonzalez, C., Martin, T., Cacho, J., Brenas, M. T., Arroyo, T., Garcia-Berrocal, B., et al. (1999). Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers. Eur. J. Clin. Invest. 29, 637-642. doi: 10.1046/j.1365-2362.1999.00471.x
40. Greenough, M. A., Volitakis, I., Li, Q. X., Laughton, K., Evin, G., Ho, M., et al. (2011). Presenilins promote the cellular uptake of copper and zinc and maintain copper chaperone of SOD1-dependent copper/zinc superoxide dismutase activity. J. Biol. Chem. 286, 9776-9786. doi: 10.1074/jbc.M110.163964
41. Grilli, M., Goffi, F., Memo, M., and Spano, P. (1996). Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J. Biol. Chem. 271, 15002-15007. doi: 10.1074/jbc.271.25.15002
42. Haase, H., and Rink, L. (2009). Functional significance of zinc-related signaling pathways in immune cells. Annu. Rev. Nutr. 29, 133-152. doi: 10.1146/annurev-nutr-080508-141119
43. Haines, A., Iliffe, S., Morgan, P., Dormandy, T., and Wood, B. (1991). Serum aluminium and zinc and other variables in patients with and without cognitive impairment in the community. Clin. Chim. Acta 198, 261-266. doi: 10.1016/0009-8981(91)90360-O
44. Hasan, R., Rink, L., and Haase, H. (2012). Zinc signals in neutrophil granulocytes are required for the formation of neutrophil extracellular traps. Innate Immun. 19, 253-264. doi: 10.1177/1753425912458815
45. Hershey, C. O., Hershey, L. A., Varnes, A., Vibhakar, S. D., Lavin, P., and Strain, W. H. (1983). Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations. Neurology 33, 1350-1353. doi: 10.1212/WNL.33.10.1350
46. Huang, L., and Tepaamorndech, S. (2013). The SLC30 family of zinc transporters - a review of current understanding of their biological and pathophysiological roles. Mol. Aspects Med. 34, 548-560. doi: 10.1016/j.mam.2012.05.008
47. Huang, Y. Z., Pan, E., Xiong, Z. Q., and McNamara, J. O. (2008). Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse. Neuron 57, 546-558. doi: 10.1016/j.neuron.2007.11.026
48. Hwang, J. J., Park, M. H., Choi, S. Y., and Koh, J. Y. (2005). Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases. J. Biol. Chem. 280, 11995-12001. doi: 10.1074/jbc.M403172200
49. Irmisch, G., Schlaefke, D., and Richter, J. (2010). Zinc and fatty acids in depression. Neurochem. Res. 35, 1376-1383. doi: 10.1007/s11064-010-0194-3
50. Jeandel, C., Nicolas, M. B., Dubois, F., Nabet-Belleville, F., Penin, F., and Cuny, G. (1989). Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35, 275-282. doi: 10.1159/000213037
51. Jomova, K., Vondrakova, D., Lawson, M., and Valko, M. (2010). Metals, oxidative stress and neurodegenerative disorders. Mol. Cell Biochem. 345, 91-104. doi: 10.1007/s11010-010-0563-x
52. Kahmann, L., Uciechowski, P., Warmuth, S., Plumakers, B., Gressner, A. M., Malavolta, M., et al. (2008). Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res. 11, 227-237. doi: 10.1089/rej.2007.0613
53. Katzman, R., Aronson, M., Fuld, P., Kawas, C., Brown, T., Morgenstern, H., et al. (1989). Development of dementing illnesses in an 80-year-old volunteer cohort. Ann. Neurol. 25, 317-324. doi: 10.1002/ana.410250402
54. Keller, K. A., Grider, A., and Coffield, J. A. (2001). Age-dependent influence of dietary zinc restriction on short-term memory in male rats. Physiol. Behav. 72, 339-348. doi: 10.1016/S0031-9384(00)00421-2
55. Kelly, E. J., Quaife, C. J., Froelick, G. J., and Palmiter, R. D. (1996). Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J. Nutr. 126, 1782-1790.
56. Krezel, A., Hao, Q., and Maret, W. (2007). The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling. Arch. Biochem. Biophys. 463, 188-200. doi: 10.1016/j.abb.2007.02.017
57. Kroczka, B., Branski, P., Palucha, A., Pilc, A., and Nowak, G. (2001). Antidepressant-like properties of zinc in rodent forced swim test. Brain Res. Bull. 55, 297-300. doi: 10.1016/S0361-9230(01)00473-7
58. Kroczka, B., Zieba, A., Dudek, D., Pilc, A., and Nowak, G. (2000). Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol. J. Pharmacol. 52, 403-406.
59. Lang, M., Wang, L., Fan, Q., Xiao, G., Wang, X., Zhong, Y., et al. (2012). Genetic inhibition of solute-linked carrier 39 family transporter 1 ameliorates abeta pathology in a Drosophila model of Alzheimer's disease. PLoS Genet. 8:e1002683. doi: 10.1371/journal.pgen.1002683
60. Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., et al. (2008). Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 7, 779-786. doi: 10.1016/S1474-4422(08)70167-4
61. Lee, J., Kim, C. H., Kim, D. G., and Ahn, Y. S. (2009). Zinc inhibits amyloid beta production from Alzheimer's amyloid precursor protein in SH-SY5Y Cells. Korean J. Physiol. Pharmacol. 13, 195-200. doi: 10.4196/kjpp.2009.13.3.195
62. Lee, J. Y., Cole, T. B., Palmiter, R. D., Suh, S. W., and Koh, J. Y. (2002). Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 99, 7705-7710. doi: 10.1073/pnas.092034699
63. Lee, J. Y., Friedman, J. E., Angel, I., Kozak, A., and Koh, J. Y. (2004). The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Neurobiol. Aging 25, 1315-1321. doi: 10.1016/j.neurobiolaging.2004.01.005
64. Lichten, L. A., and Cousins, R. J. (2009). Mammalian zinc transporters: nutritional and physiologic regulation. Annu. Rev. Nutr. 29, 153-176. doi: 10.1146/annurev-nutr-033009-083312
65. Ling, Y., Morgan, K., and Kalsheker, N. (2003). Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int. J. Biochem. Cell Biol. 35, 1505-1535. doi: 10.1016/S1357-2725(03)00133-X
66. Liuzzi, J. P., and Cousins, R. J. (2004). Mammalian zinc transporters. Annu. Rev. Nutr. 24, 151-172. doi: 10.1146/annurev.nutr.24.012003.132402
67. Lovell, M. A. (2009). A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease. J. Alzheimers Dis. 16, 471-483.
68. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998). Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52. doi: 10.1016/S0022-510X(98)00092-6
69. Lovell, M. A., Smith, J. L., and Markesbery, W. R. (2006). Elevated zinc transporter-6 in mild cognitive impairment, Alzheimer disease, and pick disease. J. Neuropathol. Exp. Neurol. 65, 489-498. doi: 10.1097/01.jnen.0000229237.98124.91
70. Lovell, M. A., Smith, J. L., Xiong, S., and Markesbery, W. R. (2005). Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Neurotox. Res. 7, 265-271. doi: 10.1007/BF03033884
71. Lyubartseva, G., and Lovell, M. A. (2012). A potential role for zinc alterations in the pathogenesis of Alzheimer's disease. Biofactors 38, 98-106. doi: 10.1002/biof.199
72. Lyubartseva, G., Smith, J. L., Markesbery, W. R., and Lovell, M. A. (2010). Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain. Brain Pathol. 20, 343-350. doi: 10.1111/j.1750-3639.2009.00283.x
73. Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., and Neels, H. (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9, 853-858. doi: 10.1006/cyto.1997.0238
74. Maes, M., D'Haese, P. C., Scharpe, S., D'Hondt, P., Cosyns, P., and De Broe, M. E. (1994). Hypozincemia in depression. J. Affect. Disord. 31, 135-140. doi: 10.1016/0165-0327(94)90117-1
75. Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., et al. (2009). The inflammatory and neurodegenerative (IandND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 24, 27-53. doi: 10.1007/s11011-008-9118-1
76. Masters, B. A., Quaife, C. J., Erickson, J. C., Kelly, E. J., Froelick, G. J., Zambrowicz, B. P., et al. (1994). Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci. 14, 5844-5857.
77. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249. doi: 10.1073/pnas.82.12.4245
78. McLoughlin, I. J., and Hodge, J. S. (1990). Zinc in depressive disorder. Acta Psychiatr. Scand. 82, 451-453. doi: 10.1111/j.1600-0447.1990.tb03077.x
79. Miller, L. M., Wang, Q., Telivala, T. P., Smith, R. J., Lanzirotti, A., and Miklossy, J. (2006). Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J. Struct. Biol. 155, 30-37. doi: 10.1016/j.jsb.2005.09.004
80. Mlyniec, K., Budziszewska, B., Reczynski, W., Sowa-Kucma, M., and Nowak, G. (2013). The role of the GPR39 receptor in zinc deficient-animal model of depression. Behav. Brain Res. 238, 30-35. doi: 10.1016/j.bbr.2012.10.020
81. Mlyniec, K., Davies, C. L., Budziszewska, B., Opoka, W., Reczynski, W., Sowa-Kucma, M., et al. (2012). Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test. Pharmacol. Rep. 64, 567-575.
82. Mlyniec, K., and Nowak, G. (2012). Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants. Pharmacol. Rep. 64, 249-255.
83. Mlyniec, K., and Nowak, G. (2013). GPR39 up-regulation after selective antidepressants. Neurochem. Int. 62, 936-939. doi: 10.1016/j.neuint.2013.02.024
84. Mocchegiani, E., Bertoni-Freddari, C., Marcellini, F., and Malavolta, M. (2005). Brain, aging and neurodegeneration: role of zinc ion availability. Prog. Neurobiol. 75, 367-390. doi: 10.1016/j.pneurobio.2005.04.005
85. Mocchegiani, E., Burkle, A., and Fulop, T. (2008). Zinc and ageing (ZINCAGE Project). Exp. Gerontol. 43, 361-362. doi: 10.1016/j.exger.2008.03.009
86. Mocchegiani, E., Costarelli, L., Giacconi, R., Piacenza, F., Basso, A., and Malavolta, M. (2011). Zinc, metallothioneins and immunosenescence: effect of zinc supply as nutrigenomic approach. Biogerontology 12, 455-465. doi: 10.1007/s10522-011-9337-4
87. Mocchegiani, E., Malavolta, M., Costarelli, L., Giacconi, R., Cipriano, C., Piacenza, F., et al. (2010). Zinc, metallothioneins and immunosenescence. Proc. Nutr. Soc. 69, 290-299. doi: 10.1017/S0029665110001862
88. Molina, J. A., Jimenez-Jimenez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., Gonzalez-Munoz, M. J., et al. (1998). Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J. Neural Transm. 105, 479-488. doi: 10.1007/s007020050071
89. Narang, R. L., Gupta, K. R., Narang, A. P., and Singh, R. (1991). Levels of copper and zinc in depression. Indian J. Physiol. Pharmacol. 35, 272-274.
90. Nguyen, P. H., Grajeda, R., Melgar, P., Marcinkevage, J., DiGirolamo, A. M., Flores, R., et al. (2009). Micronutrient supplementation may reduce symptoms of depression in Guatemalan women. Arch. Latinoam. Nutr. 59, 278-286.
91. Noh, K. M., and Koh, J. Y. (2000). Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J. Neurosci. 20, RC111.
92. Nowak, G., Siwek, M., Dudek, D., Zieba, A., and Pilc, A. (2003a). Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol. J. Pharmacol. 55, 1143-1147.
93. Nowak, G., Szewczyk, B., Wieronska, J. M., Branski, P., Palucha, A., Pilc, A., et al. (2003b). Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res. Bull. 61, 159-164. doi: 10.1016/S0361-9230(03)00104-7
94. Nowak, G., Zieba, A., Dudek, D., Krosniak, M., Szymaczek, M., and Schlegel-Zawadzka, M. (1999). Serum trace elements in animal models and human depression. Part I. Zinc. Hum. Psychopharmacol. Clin. Exp. 14, 83-86.
95. Panayi, A. E., Spyrou, N. M., Iversen, B. S., White, M. A., and Part, P. (2002). Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J. Neurol. Sci. 195, 1-10. doi: 10.1016/S0022-510X(01)00672-4
96. Paoletti, P., Vergnano, A. M., Barbour, B., and Casado, M. (2009). Zinc at glutamatergic synapses. Neuroscience 158, 126-136. doi: 10.1016/j.neuroscience.2008.01.061
97. Perry, D. K., Smyth, M. J., Stennicke, H. R., Salvesen, G. S., Duriez, P., Poirier, G. G., et al. (1997). Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J. Biol. Chem. 272, 18530-18533. doi: 10.1074/jbc.272.30.18530
98. Piechal, A., Blecharz-Klin, K., Pyrzanowska, J., and Widy-Tyszkiewicz, E. (2012). Maternal zinc supplementation improves spatial memory in rat pups. Biol. Trace Elem. Res. 147, 299-308. doi: 10.1007/s12011-012-9323-y
99. Plum, L. M., Rink, L., and Haase, H. (2010). The essential toxin: impact of zinc on human health. Int. J. Environ. Res. Public Health 7, 1342-1365. doi: 10.3390/ijerph7041342
100. Quaife, C. J., Findley, S. D., Erickson, J. C., Froelick, G. J., Kelly, E. J., Zambrowicz, B. P., et al. (1994). Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33, 7250-7259. doi: 10.1021/bi00189a029
101. Railey, A. M., Micheli, T. L., Wanschura, P. B., and Flinn, J. M. (2010). Alterations in fear response and spatial memory in pre- and post-natal zinc supplemented rats: remediation by copper. Physiol. Behav. 100, 95-100. doi: 10.1016/j.physbeh.2010.01.040
102. Ranjbar, E., Shams, J., Sabetkasaei, M., Shirazi, M., Rashidkhani, B., Mostafavi, A., et al. (2013). Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr. Neurosci. doi: 10.1179/1476830513Y.0000000066. [Epub ahead of print].
103. Religa, D., Strozyk, D., Cherny, R. A., Volitakis, I., Haroutunian, V., Winblad, B., et al. (2006). Elevated cortical zinc in Alzheimer disease. Neurology 67, 69-75. doi: 10.1212/01.wnl.0000223644.08653.b5
104. Roozbeh, J., Sharifian, M., Ghanizadeh, A., Sahraian, A., Sagheb, M. M., Shabani, S., et al. (2011). Association of zinc deficiency and depression in the patients with end-stage renal disease on hemodialysis. J. Ren. Nutr. 21, 184-187. doi: 10.1053/j.jrn.2010.05.015
105. Rosa, A. O., Lin, J., Calixto, J. B., Santos, A. R., and Rodrigues, A. L. (2003). Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav. Brain Res. 144, 87-93. doi: 10.1016/S0166-4328(03)00069-X
106. Roy, A., Evers, S. E., Avison, W. R., and Campbell, M. K. (2010). Higher zinc intake buffers the impact of stress on depressive symptoms in pregnancy. Nutr. Res. 30, 695-704. doi: 10.1016/j.nutres.2010.09.011
107. Rulon, L. L., Robertson, J. D., Lovell, M. A., Deibel, M. A., Ehmann, W. D., and Markesber, W. R. (2000). Serum zinc levels and Alzheimer's disease. Biol. Trace Elem. Res. 75, 79-85. doi: 10.1385/BTER:75:1-3:79
108. Sahu, R. N., Pandey, R. S., Subhash, M. N., Arya, B. Y., Padmashree, T. S., and Srinivas, K. N. (1988). CSF zinc in Alzheimer's type dementia. Biol. Psychiatry 24, 480-482. doi: 10.1016/0006-3223(88)90190-4
109. Samudralwar, D. L., Diprete, C. C., Ni, B. F., Ehmann, W. D., and Markesbery, W. R. (1995). Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130, 139-145. doi: 10.1016/0022-510X(95)00018-W
110. Sandstead, H. H. (2012). Subclinical zinc deficiency impairs human brain function. J. Trace Elem. Med. Biol. 26, 70-73. doi: 10.1016/j.jtemb.2012.04.018
111. Sato, M., and Kondoh, M. (2002). Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J. Exp. Med. 196, 9-22. doi: 10.1620/tjem.196.9
112. Sawada, T., and Yokoi, K. (2010). Effect of zinc supplementation on mood states in young women: a pilot study. Eur. J. Clin. Nutr. 64, 331-333. doi: 10.1038/ejcn.2009.158
113. Sensi, S. L., Paoletti, P., Koh, J. Y., Aizenman, E., Bush, A. I., and Hershfinkel, M. (2011). The neurophysiology and pathology of brain zinc. J. Neurosci. 31, 16076-16085. doi: 10.1523/JNEUROSCI.3454-11.2011
114. Sensi, S. L., Rapposelli, I. G., Frazzini, V., and Mascetra, N. (2008). Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Exp. Gerontol. 43, 488-492. doi: 10.1016/j.exger.2007.10.018
115. Sensi, S. L., Ton-That, D., Sullivan, P. G., Jonas, E. A., Gee, K. R., Kaczmarek, L. K., et al. (2003). Modulation of mitochondrial function by endogenous Zn2+ pools. Proc. Natl. Acad. Sci. U.S.A. 100, 6157-6162. doi: 10.1073/pnas.1031598100
116. Shore, D., Henkin, R. I., Nelson, N. R., Agarwal, R. P., and Wyatt, R. J. (1984). Hair and serum copper, zinc, calcium, and magnesium concentrations in Alzheimer-type dementia. J. Am. Geriatr. Soc. 32, 892-895.
117. Siwek, M., Dudek, D., Paul, I. A., Sowa-Kucma, M., Zieba, A., Popik, P., et al. (2009). Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J. Affect. Disord. 118, 187-195. doi: 10.1016/j.jad.2009.02.014
118. Siwek, M., Dudek, D., Schlegel-Zawadzka, M., Morawska, A., Piekoszewski, W., Opoka, W., et al. (2010). Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J. Affect. Disord. 126, 447-452. doi: 10.1016/j.jad.2010.04.024
119. Small, D. H., and Cappai, R. (2006). Alois Alzheimer and Alzheimer's disease: a centennial perspective. J. Neurochem. 99, 708-710. doi: 10.1111/j.1471-4159.2006.04212.x
120. Smart, T. G., Hosie, A. M., and Miller, P. S. (2004). Zn2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist 10, 432-442. doi: 10.1177/1073858404263463
121. Smith, J. L., Xiong, S., Markesbery, W. R., and Lovell, M. A. (2006). Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain. Neuroscience 140, 879-888. doi: 10.1016/j.neuroscience.2006.02.049
122. Sowa-Kucma, M., Legutko, B., Szewczyk, B., Novak, K., Znojek, P., Poleszak, E., et al. (2008). Antidepressant-like activity of zinc: further behavioral and molecular evidence. J. Neural Transm. 115, 1621-1628. doi: 10.1007/s00702-008-0115-7
123. Suh, S. W., Jensen, K. B., Jensen, M. S., Silva, D. S., Kesslak, P. J., Danscher, G., et al. (2000). Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res. 852, 274-278. doi: 10.1016/S0006-8993(99)02096-X
124. Suh, S. W., Won, S. J., Hamby, A. M., Yoo, B. H., Fan, Y., Sheline, C. T., et al. (2009). Decreased brain zinc availability reduces hippocampal neurogenesis in mice and rats. J. Cereb. Blood Flow Metab. 29, 1579-1588. doi: 10.1038/jcbfm.2009.80
125. Szewczyk, B., Branski, P., Wieronska, J. M., Palucha, A., Pilc, A., and Nowak, G. (2002). Interaction of zinc with antidepressants in the forced swimming test in mice. Pol. J. Pharmacol. 54, 681-685.
126. Szewczyk, B., Poleszak, E., Sowa-Kucma, M., Wrobel, A., Slotwinski, S., Listos, J., et al. (2010). The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids 39, 205-217. doi: 10.1007/s00726-009-0412-y
127. Szewczyk, B., Poleszak, E., Wlaz, P., Wrobel, A., Blicharska, E., Cichy, A., et al. (2009). The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 323-329. doi: 10.1016/j.pnpbp.2008.12.011
128. Takeda, A. (2000). Movement of zinc and its functional significance in the brain. Brain Res. Brain Res. Rev. 34, 137-148. doi: 10.1016/S0165-0173(00)00044-8
129. Takeda, A., Tamano, H., Tochigi, M., and Oku, N. (2005). Zinc homeostasis in the hippocampus of zinc-deficient young adult rats. Neurochem. Int. 46, 221-225. doi: 10.1016/j.neuint.2004.10.003
130. Tamano, H., Kan, F., Kawamura, M., Oku, N., and Takeda, A. (2009). Behavior in the forced swim test and neurochemical changes in the hippocampus in young rats after 2-week zinc deprivation. Neurochem. Int. 55, 536-541. doi: 10.1016/j.neuint.2009.05.011
131. Tassabehji, N. M., Corniola, R. S., Alshingiti, A., and Levenson, C. W. (2008). Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav. 95, 365-369. doi: 10.1016/j.physbeh.2008.06.017
132. Thompson, C. M., Markesbery, W. R., Ehmann, W. D., Mao, Y. X., and Vance, D. E. (1988). Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 9, 1-7.
133. Trombley, P. Q., Horning, M. S., and Blakemore, L. J. (1998). Carnosine modulates zinc and copper effects on amino acid receptors and synaptic transmission. Neuroreport 9, 3503-3507. doi: 10.1097/00001756-199810260-00031
134. Tsuji, S., Kobayashi, H., Uchida, Y., Ihara, Y., and Miyatake, T. (1992). Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J. 11, 4843-4850.
135. Uchida, Y., Takio, K., Titani, K., Ihara, Y., and Tomonaga, M. (1991). The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7, 337-347. doi: 10.1016/0896-6273(91)90272-2
136. Vural, H., Demirin, H., Kara, Y., Eren, I., and Delibas, N. (2010). Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J.Trace Elem. Med. Biol. 24, 169-173. doi: 10.1016/j.jtemb.2010.02.002
137. Wang, T., Wang, C. Y., Shan, Z. Y., Teng, W. P., and Wang, Z. Y. (2012). Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AbetaPP/PS1 transgenic mouse brain. J. Alzheimers Dis. 29, 549-559.
138. Watanabe, M., Tamano, H., Kikuchi, T., and Takeda, A. (2010). Susceptibility to stress in young rats after 2-week zinc deprivation. Neurochem. Int. 56, 410-416. doi: 10.1016/j.neuint.2009.11.014
139. Wenstrup, D., Ehmann, W. D., and Markesbery, W. R. (1990). Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res. 533, 125-131. doi: 10.1016/0006-8993(90)91804-P
140. Whittle, N., Lubec, G., and Singewald, N. (2009). Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids 36, 147-158. doi: 10.1007/s00726-008-0195-6
141. Wilquet, V., and De, S. B. (2004). Amyloid-beta precursor protein processing in neurodegeneration. Curr. Opin. Neurobiol. 14, 582-588. doi: 10.1016/j.conb.2004.08.001
142. Wojcik, J., Dudek, D., Schlegel-Zawadzka, M., Grabowska, M., Marcinek, A., Florek, E., et al. (2006). Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol. Rep. 58, 571-576.
143. Wong, C. P., Magnusson, K. R., and Ho, E. (2013). Increased inflammatory response in aged mice is associated with age-related zinc deficiency and zinc transporter dysregulation. J. Nutr. Biochem. 24, 353-359. doi: 10.1016/j.jnutbio.2012.07.005
144. Yang, Y., Jing, X. P., Zhang, S. P., Gu, R. X., Tang, F. X., Wang, X. L., et al. (2013). High dose zinc supplementation induces hippocampal zinc deficiency and memory impairment with inhibition of BDNF signaling. PLoS ONE 8:e55384. doi: 10.1371/journal.pone.0055384
145. Yu, W. H., Lukiw, W. J., Bergeron, C., Niznik, H. B., and Fraser, P. E. (2001). Metallothionein III is reduced in Alzheimer's disease. Brain Res. 894, 37-45. doi: 10.1016/S0006-8993(00)03196-6
146. Zhang, L. H., Wang, X., Stoltenberg, M., Danscher, G., Huang, L., and Wang, Z. Y. (2008). Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain. Brain Res. Bull. 77, 55-60. doi: 10.1016/j.brainresbull.2008.03.014
147. Zhang, L. H., Wang, X., Zheng, Z. H., Ren, H., Stoltenberg, M., Danscher, G., et al. (2010). Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiol. Aging 31, 74-87. doi: 10.1016/j.neurobiolaging.2008.02.018